TY - JOUR
T1 - Interstitial growth as an aggressive growth pattern in primary lung cancer
AU - Suzuki, Shigeki
AU - Aokage, Keiju
AU - Hishida, Tomoyuki
AU - Yoshida, Junji
AU - Kuwata, Takeshi
AU - Yamauchi, Chisako
AU - Tsuboi, Masahiro
AU - Ishii, Genichiro
N1 - Publisher Copyright:
© 2016, Springer-Verlag Berlin Heidelberg.
PY - 2016/7/1
Y1 - 2016/7/1
N2 - Purpose: Interstitial growth (IG), which is defined as tumor cells continuously growing into the alveolar septa at the tumor periphery, was originally reported as a growth pattern of metastatic sarcoma of the lung. On the other hand, IG in the primary lung cancers has not been well described. This study aimed to examine clinicopathological features of primary lung cancer that harbors IG. Methods: A total of 2558 primary lung cancers which were resected from 2003 to 2012 in our hospital were examined for IG. We compared clinicopathological data and prognoses between patients with IG+ and IG− specimens. Results: Thirty-three cases out of 2558 (1.3 %) had IG components. IG was significantly more associated with positive smoking history, advanced pathological stage, presence of vascular invasion and pleural invasion. Thirty-three IG+ cases include nine pleomorphic carcinoma, nine squamous cell carcinoma and eight adenocarcinoma. Interestingly, nine (24 %) out of 38 pleomorphic carcinoma specimens had IG components, which was a higher rate than any other histological subtypes. The IG+ cancers had significantly shorter overall and recurrence-free survival than did the IG− cancers. Conclusions: We firstly reported on IG in various types of primary lung cancer. IG appears to be a sign of an aggressive lung cancer phenotype, mainly found in pleomorphic carcinoma.
AB - Purpose: Interstitial growth (IG), which is defined as tumor cells continuously growing into the alveolar septa at the tumor periphery, was originally reported as a growth pattern of metastatic sarcoma of the lung. On the other hand, IG in the primary lung cancers has not been well described. This study aimed to examine clinicopathological features of primary lung cancer that harbors IG. Methods: A total of 2558 primary lung cancers which were resected from 2003 to 2012 in our hospital were examined for IG. We compared clinicopathological data and prognoses between patients with IG+ and IG− specimens. Results: Thirty-three cases out of 2558 (1.3 %) had IG components. IG was significantly more associated with positive smoking history, advanced pathological stage, presence of vascular invasion and pleural invasion. Thirty-three IG+ cases include nine pleomorphic carcinoma, nine squamous cell carcinoma and eight adenocarcinoma. Interestingly, nine (24 %) out of 38 pleomorphic carcinoma specimens had IG components, which was a higher rate than any other histological subtypes. The IG+ cancers had significantly shorter overall and recurrence-free survival than did the IG− cancers. Conclusions: We firstly reported on IG in various types of primary lung cancer. IG appears to be a sign of an aggressive lung cancer phenotype, mainly found in pleomorphic carcinoma.
KW - Interstitial growth
KW - Lung cancer
KW - Pleomorphic carcinoma
KW - Vascular invasion
UR - http://www.scopus.com/inward/record.url?scp=84964432747&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84964432747&partnerID=8YFLogxK
U2 - 10.1007/s00432-016-2168-6
DO - 10.1007/s00432-016-2168-6
M3 - Article
C2 - 27112455
AN - SCOPUS:84964432747
SN - 0171-5216
VL - 142
SP - 1591
EP - 1598
JO - Journal of Cancer Research and Clinical Oncology
JF - Journal of Cancer Research and Clinical Oncology
IS - 7
ER -